Wednesday, October 9, 2013

A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis


Palmar and axillary hyperhidrosis improved in >70% of the patients, and 47.8% of those presented great improvement. Plantar hyperhidrosis improved in >90% of the patients. Most patients (65.2%) showed improvements in their quality of life. The side effects were minor, with dry mouth being the most frequent (47.8%).

Journal of Vascular SurgeryVolume 55, Issue 6June 2012Pages 1696-1700